The recent finding that COVID19 increases GCPII expression in brain [13] are consistent with the literature showing that inflammation increases GCPII expression in animals [8–10], and that COVID19 can induce prolonged deficits in the executive and working memory functions that rely on the dlPFC [61–64]. The gene discussed is FOLH1; the disease is COVID-19.